Intellihealth Launches Evolve Mobile 3.0

Intellihealth, a leading health-tech software and clinical services company that delivers a comprehensive and clinically proven medical model for treating obesity, has introduced version 3.0 of Evolve Mobile, the patient-side mobile app companion to the Evolve software-as-a-service platform for healthcare providers.

Intellihealth’s EvolveTM is a turnkey medical obesity treatment solution that easily integrates into any practice and streamlines all aspects of care, including assessment, diagnosis, prescription and treatment. Patients’ individualized treatment plans — addressing diet, behavior and psychology, as well as pharmacotherapy when appropriate — are developed and continually refined by expert obesity clinicians based on factors such as their medical history and health risks, electronic health record information, data from wearables and connected devices, and learning center progress.

Evolve Mobile 3.0 includes two significant new features: medication monitoring, which enables patients to set up personalized reminders to take their anti-obesity medications regularly and allows both patients and providers to monitor patterns to make sure prescriptions are being followed; and Apple Health and Google Fit integration, which supports seamless access to weight, blood pressure and heart-rate data from connected devices. Together, these tools offer patients and providers a more comprehensive view of overall health and program compliance over time. The upgrade also incorporates a range of performance improvements and updates throughout the app.

“Remote medication monitoring can improve the efficacy of treatment for many chronic diseases, and obesity is no exception,” said Venky Surya, CPTO at Intellihealth. “With Evolve Mobile 3.0, care teams can better monitor their patients’ medication usage as well as a variety of critical indicators, allowing them to closely track patients’ overall health and weight-loss progress and respond quickly when individualized treatment plans need to be adjusted. This reinforces positive messaging and leads to better patient engagement in our programs.”

The new features extend the app’s existing capabilities, which include meal planning tailored to individual dietary preferences; easy food, weight and activity logging; regular virtual visits and messaging with care team members; and educational resources and other tools to support engagement.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution